Hyperthermic intraperitoneal chemotherapy in ovarian cancer: a comprehensive review. [PDF]
Front OncolLi Y, Xu X.
europepmc +1 more source
Logistic regression analysis of risk factors for abdominal adhesion during hyperthermic intraperitoneal chemotherapy for ovarian cancer. [PDF]
Oncol LettYao J, Chen J.
europepmc +1 more source
Advances and challenges in the application of prophylactic hyperthermic intraperitoneal chemotherapy for gastric cancer. [PDF]
Front OncolLiu M, Shen X.
europepmc +1 more source
Sclerosing Encapsulating Peritonitis Is More Common Following Repeat Hyperthermic Intraperitoneal Chemotherapy. [PDF]
CureusDavydov A +2 more
europepmc +1 more source
Impact of Omission of Hyperthermic Intraperitoneal Chemotherapy for Treatment of Colorectal Peritoneal Metastases. [PDF]
Perm JIm K, Yoshinaga S, Leung AM.
europepmc +1 more source
Catheter based intraperitoneal chemotherapy using taxane for peritoneal metastases from gastric cancer: from bench to bedside-a narrative review. [PDF]
Gastric CancerKitayama J.
europepmc +1 more source
The impact on sexual wellbeing after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer treatment. [PDF]
Gynecol Oncol RepFalla-Zuniga LF +8 more
europepmc +1 more source
Surgical education video: Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Ovarian Cancer. [PDF]
Gynecol Oncol RepHuizar GD +3 more
europepmc +1 more source
Sustained disease control in ovarian carcinosarcoma treated with postoperative hyperthermic intraperitoneal chemotherapy and targeted maintenance: a case report. [PDF]
Front Med (Lausanne)Xu S +8 more
europepmc +1 more source
Advanced local jejunal carcinoma treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a case report and review of the literature. [PDF]
Ann Med Surg (Lond)Armosh GA +6 more
europepmc +1 more source